TrialBMC nephrology2022

Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.

Fabio Solis-Jimenez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.